Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ritu Banerjee, MD, PhD
Vanderbilt University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Attikon University General Hospital
Chaïdári, Attica, Greece
- Tzaneio General Hospital
Piraeus, Greece
- Kasturba Medical College, Mangalore
Attāvara, Mangalore, India
- Rambam Health Care Campus
Haifa, Israel
- Meir Medical Center
Kfar Saba, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Complexo Hospitalario Universitario A Coruña (chuac) Sergas
A Coruña, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2023
- Primary completion
- 18 Jun 2025
- Completion
- 18 Jun 2025
- Last update posted
- 8 Jul 2025
- Registered enrollment
- 900
- Registry id
- NCT06174649
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.